Answer
Yes, immune reactivation syndrome can occur when Truvada is started as part of combination antiretroviral therapy in people with HIV and severe immune deficiency, causing inflammatory reactions to asymptomatic or residual opportunistic pathogens that may cause serious conditions or worsen symptoms.
Sources for this answer
- Truvada film-coated tabletsGilead Sciences Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 43Document updated
Sources checked